Shopping Cart
- Remove All
- Your shopping cart is currently empty
Zolbetuximab MMAE (IMAB362 MMAE) is a compound targeting Claudin 18.2 (CLDN18.2) with anti-cancer activity, used in the study of gastric and pancreatic cancers.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $1,690 | In Stock | |
5 mg | $3,430 | In Stock | |
10 mg | $4,630 | In Stock | |
25 mg | $6,880 | In Stock |
Description | Zolbetuximab MMAE (IMAB362 MMAE) is a compound targeting Claudin 18.2 (CLDN18.2) with anti-cancer activity, used in the study of gastric and pancreatic cancers. |
In vitro | Zolbetuximab MMAE binds to ClDN18.2-positive (CLDN18.2+) cells with high affinity and induces antibody-dependent cell-mediated cytotoxicity (ADCC). [1] |
In vivo | Zolbetuximab MMAE blocked the growth of CLDN18.2+ gastric and pancreatic cancer cell line xenotransplantation (CDX) models. [1] |
Alias | IMAB362 MMAE |
Molecular Weight | 150 kDa |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.